Recurrently deregulated lncRNAs in hepatocellular carcinoma.
Recurrently deregulated lncRNAs in hepatocellular carcinoma.
复制标题
肝细胞癌中 lncRNA 经常失调。
DOI:
10.1038/ncomms14421
复制
发表时间:
2017-02-13
影响因子:
16.6
通讯作者:
Lu ZJ
中科院分区:
文献类型:
--
作者:
Yang Y;Chen L;Gu J;Zhang H;Yuan J;Lian Q;Lv G;Wang S;Wu Y;Yang YT;Wang D;Liu Y;Tang J;Luo G;Li Y;Hu L;Sun X;Wang D;Guo M;Xi Q;Xi J;Wang H;Zhang MQ;Lu ZJ
Hepatocellular carcinoma (HCC) cells often invade the portal venous system and subsequently develop into portal vein tumour thrombosis (PVTT). Long noncoding RNAs (lncRNAs) have been associated with HCC, but a comprehensive analysis of their specific association with HCC metastasis has not been conducted. Here, by analysing 60 clinical samples' RNA-seq data from 20 HCC patients, we have identified and characterized 8,603 candidate lncRNAs. The expression patterns of 917 recurrently deregulated lncRNAs are correlated with clinical data in a TCGA cohort and published liver cancer data. Matched array data from the 60 samples show that copy number variations (CNVs) and alterations in DNA methylation contribute to the observed recurrent deregulation of 235 lncRNAs. Many recurrently deregulated lncRNAs are enriched in co-expressed clusters of genes related to cell adhesion, immune response and metabolic processes. Candidate lncRNAs related to metastasis, such as HAND2-AS1, were further validated using RNAi-based loss-of-function assays. Thus, we provide a valuable resource of functional lncRNAs and biomarkers associated with HCC tumorigenesis and metastasis. Long noncoding-RNAs have been linked to hepatocellular carcinoma (HCC) and some can be used as prognostic markers. Here the authors, by analysing RNA-seq in 60 clinical samples from 20 patients, provide a resource of functional lncRNAs and biomarkers associated with HCC tumorigenesis and metastasis.